PERRY MICHAEL S
SEC insider (Form 3/4/5 filer). CIK 0001250379. Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in PASADENA, CA.
Companies PERRY MICHAEL S has filed insider reports for
- ARROWHEAD PHARMACEUTICALS, INC. (ARWR): Director
PERRY MICHAEL S
CIK: 0001250379
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 18, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect11.6K shares at avg. $87.30$1.0M - Dec 16, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AwardDirect7.8K shares- - Dec 5, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect16.3K shares at avg. $61.03$992K - Dec 18, 2024ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AwardDirect16.7K shares at avg. $22.99$385K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 11,600 | $87.30 | $1,012,680 | Direct |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award | 7,819 | - | - | Direct |
| Dec 5, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 16,250 | $61.03 | $991,738 | Direct |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award | 16,733 | $22.99 | $384,692 | Direct |
1-4 of 4 transactions